UK begins H5N1 mRNA bird flu vaccine trial with 4,000 volunteers
The UK has begun a 4,000-volunteer H5N1 bird flu vaccine trial using mRNA technology. The study will assess safety and immune response, with CEPI providing £40m in funding.
mRNA
GeneRelated News
Rznomics to present interim U.S. trial results for liver cancer candidate RZ-001 at AACR
Rznomics said it will present interim AACR results for liver cancer candidate RZ-001 from a U.S. trial in patients with hepatocellular carcinoma. Tumor-shrinking responses were observed, and about 23% experienced complete disappearance of cancer cells.
CAMP4 Therapeutics Announces Nasdaq Inducement Grants to Newly Hired Employees
CAMP4 Therapeutics announced Nasdaq inducement stock option grants for newly hired employees in February and April 2026. The awards covered 51,000 shares in total and vest over four years.
AI drug discovery push expands with NVIDIA-Eli Lilly lab and data-driven platforms
NVIDIA and Eli Lilly announced a $1 billion AI co-innovation lab as AI drug discovery expands across research, trials and manufacturing. Companies including Recursion and Tempus are using large biological and clinical datasets to speed development and support precision medicine.
Amino Acid Supplement Boosts mRNA and CRISPR Therapy Delivery Up to 20-Fold
Researchers discovered that adding three common amino acids to lipid nanoparticles dramatically improves mRNA and CRISPR gene editing delivery, boosting efficiency up to 20-fold and raising gene editing success rates from 25% to nearly 90%.
Cardiovascular Biologics and Cell Therapy Markets Project Strong Growth Through 2033
The cardiovascular biologics market is projected to reach $4.23 billion by 2033, while the cell therapy market is expected to reach $5.38 billion by 2032, driven by RNA-based therapies and regulatory approvals.
mRNA Vaccine Market Projected to Reach $82.61 Billion by 2030 Amid Safety Debates
The global mRNA and next-generation vaccine platforms market is expected to grow from $39.69 billion in 2025 to $82.61 billion by 2030 at a 15.8% CAGR, driven by personalized medicine demand and infectious disease applications, while safety concerns and regulatory scrutiny continue.
Kennedy Faces Backlash From Anti-Vaccine Supporters Over Policy Reversals
Health Secretary Robert F. Kennedy Jr. is drawing criticism from anti-vaccine supporters who believe he has not gone far enough in dismantling vaccine programs, following regulatory reversals including the restoration of an mRNA flu shot review.
FDA Reverses Course on Moderna mRNA Flu Vaccine After Initial Rejection
The FDA reversed its decision to reject Moderna's mRNA influenza vaccine application, accepting it for review one week after an initial refusal-to-file that reportedly involved senior leaders overruling staff advice.
New Brain Cell Mapping Technology Reveals Protein Production Patterns in Memory Neurons
Scientists developed Ribo-STAMP technology to map protein production across nearly 20,000 individual mouse brain cells, revealing unexpected differences in how memory neurons translate proteins and potential insights into neurological disorders.